These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 30468386)
1. Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity. Jarrad AM; Ang CW; Debnath A; Hahn HJ; Woods K; Tan L; Sykes ML; Jones AJ; Pelingon R; Butler MS; Avery VM; West NP; Karoli T; Blaskovich MAT; Cooper MA J Med Chem; 2018 Dec; 61(24):11349-11371. PubMed ID: 30468386 [TBL] [Abstract][Full Text] [Related]
2. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis. Jarrad AM; Debnath A; Miyamoto Y; Hansford KA; Pelingon R; Butler MS; Bains T; Karoli T; Blaskovich MA; Eckmann L; Cooper MA Eur J Med Chem; 2016 Sep; 120():353-62. PubMed ID: 27236016 [TBL] [Abstract][Full Text] [Related]
3. New synthesis and antiparasitic activity of model 5-aryl-1-methyl-4-nitroimidazoles. Saadeh HA; Mosleh IM; El-Abadelah MM Molecules; 2009 Jul; 14(8):2758-67. PubMed ID: 19701122 [TBL] [Abstract][Full Text] [Related]
4. Antitubercular and Antiparasitic 2-Nitroimidazopyrazinones with Improved Potency and Solubility. Ang CW; Tan L; Sykes ML; AbuGharbiyeh N; Debnath A; Reid JC; West NP; Avery VM; Cooper MA; Blaskovich MAT J Med Chem; 2020 Dec; 63(24):15726-15751. PubMed ID: 33151678 [TBL] [Abstract][Full Text] [Related]
5. Recent Progress in the Discovery and Development of 2-Nitroimidazooxazines and 6-Nitroimidazooxazoles to Treat Tuberculosis and Neglected Tropical Diseases. Showalter HD Molecules; 2020 Sep; 25(18):. PubMed ID: 32927749 [TBL] [Abstract][Full Text] [Related]
6. Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agents. Tao X; Gao C; Huang ZG; Luo W; Liu KL; Peng CT; Ding CZ; Li J; Chen SH; Yu LT Bioorg Med Chem Lett; 2019 Sep; 29(17):2511-2515. PubMed ID: 31353295 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824). Palmer BD; Sutherland HS; Blaser A; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA; Thompson AM J Med Chem; 2015 Apr; 58(7):3036-59. PubMed ID: 25781074 [TBL] [Abstract][Full Text] [Related]
10. Chemical constituents of Osyris alba and their antiparasitic activities. Al-Jaber HI; Mosleh IM; Mallouh A; Abu Salim OM; Abu Zarga MH J Asian Nat Prod Res; 2010 Sep; 12(9):814-20. PubMed ID: 20839131 [TBL] [Abstract][Full Text] [Related]
11. Antigiardial and antiamebic activities of fexinidazole and its metabolites: new drug leads for giardiasis and amebiasis. Escrig JI; Miyamoto Y; Aznar AD; Eckmann L; Debnath A Antimicrob Agents Chemother; 2024 Jan; 68(1):e0073123. PubMed ID: 38063401 [TBL] [Abstract][Full Text] [Related]
12. Alkylated/aminated nitroimidazoles and nitroimidazole-7-chloroquinoline conjugates: Synthesis and anti-mycobacterial evaluation. Shalini ; Viljoen A; Kremer L; Kumar V Bioorg Med Chem Lett; 2018 May; 28(8):1309-1312. PubMed ID: 29551480 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel hybrid molecules from precursors with known antiparasitic activity. Saadeh HA; Mosleh IM; Mubarak MS Molecules; 2009 Apr; 14(4):1483-94. PubMed ID: 19384280 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles. Kim P; Zhang L; Manjunatha UH; Singh R; Patel S; Jiricek J; Keller TH; Boshoff HI; Barry CE; Dowd CS J Med Chem; 2009 Mar; 52(5):1317-28. PubMed ID: 19209889 [TBL] [Abstract][Full Text] [Related]
15. Nitroimidazolyl hydrazones are better amoebicides than their cyclized 1,3,4-oxadiazoline analogues: In vitro studies and Lipophilic efficiency analysis. Wani MY; Bhat AR; Azam A; Athar F Eur J Med Chem; 2013 Jun; 64():190-9. PubMed ID: 23644202 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of antitubercular nitroimidazoles. 3. Exploration of the linker and lipophilic tail of ((s)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybenzyl)amine (6-amino PA-824). Cherian J; Choi I; Nayyar A; Manjunatha UH; Mukherjee T; Lee YS; Boshoff HI; Singh R; Ha YH; Goodwin M; Lakshminarayana SB; Niyomrattanakit P; Jiricek J; Ravindran S; Dick T; Keller TH; Dartois V; Barry CE J Med Chem; 2011 Aug; 54(16):5639-59. PubMed ID: 21755942 [TBL] [Abstract][Full Text] [Related]